Lineage, Inc. Common Stock (LINE)vsPresidio Property Trust (SQFT)
LINE
Lineage, Inc. Common Stock
$35.99
-1.64%
REAL ESTATE · Cap: $8.93B
SQFT
Presidio Property Trust
$3.61
-2.43%
REAL ESTATE · Cap: $5.20M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 31747% more annual revenue ($5.36B vs $16.81M). LINE leads profitability with a -1.9% profit margin vs -49.2%. LINE earns a higher WallStSmart Score of 36/100 (F).
LINE
Hold36
out of 100
Grade: F
SQFT
Avoid32
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$35.99
$125.50 discount
Intrinsic value data unavailable for SQFT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 0.6%
ROE of -25.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : SQFT
The strongest argument for SQFT centers on Price/Book.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : SQFT
The primary concerns for SQFT are EPS Growth, Market Cap, Operating Margin.
Key Dynamics to Monitor
LINE is growing revenue faster at -0.2% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LINE scores higher overall (36/100 vs 32/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Presidio Property Trust
REAL ESTATE · REIT - DIVERSIFIED · USA
The Company is an internally managed diversified REIT (formerly called NetREIT).
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?